Incorporating Fecal Calprotectin in Clinical Practice for Patients with Moderate to Severely Active Ulcerative Colitis Treated with Biologics or Small Molecule Inhibitors

BACKGROUND: We applied the GRADE (Grading of Recommendations Assessment, Development and Evaluation) framework to evaluate the performance of fecal calprotectin (FC) as an alternative to endoscopy in patients with moderate-severe ulcerative colitis (UC) treated with a biologic agent or tofacitinib....

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Am J Gastroenterol
Main Authors: Dulai, Parambir S., Battat, Robert, Barsky, Maria, Nguyen, Nghia H., Ma, Christopher, Narula, Neeraj, Mosli, Mahmoud, Casteele, Niels Vande, Boland, Brigid S., Prokop, Larry, Murad, M. Hassan, D’Haens, Geert, Feagan, Brian G., Sandborn, William J., Jairath, Vipul, Singh, Siddharth
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7274901/
https://ncbi.nlm.nih.gov/pubmed/32384283
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14309/ajg.0000000000000596
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados